FarhanaLatifMD

Heart Failure & Transplantation

Assistant Professor, Medicine, Columbia University College of Phys & Surg

Overview of Dr. Latif

Dr. Farhana Latif is a cardiologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, NewYork-Presbyterian/Columbia University Irving Medical Center, and NYU Langone Hospitals. She received her medical degree from Albany Medical College and has been in practice 19 years. She is one of 527 doctors at NYU Langone Hospitals and one of 694 doctors at New York-Presbyterian Hospital who specialize in Cardiology. She has more than 70 publications and over 500 citings.

Office
622 W 168th St
Ph-3 Stem 137
New York, NY 10032
Book by Phone+1(929) 334-3436

Fax+1 212-342-3414

Education & Training

Montefiore Medical Center/Albert Einstein College of Medicine (Montefiore)Fellowship, Cardiovascular Disease, 2002 - 2007
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 1998 - 2001
Albany Medical CollegeClass of 1998

Certifications & Licensure

FL State Medical License 2022 - Present
NY State Medical License 2001 - 2025
NJ State Medical License 2008 - 2009
American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014

Publications & Presentations

PubMed

1 citations
Bridge to simultaneous heart-kidney transplantation via extracorporeal life support: National outcomes in the new heart allocation policy era.
Iris Feng, Paul A Kurlansky, Yanling Zhao, Krushang Patel, Morgan K Moroi
The Journal of Heart and Lung Transplantation. 2025-01-01
Elevated Donor-Derived Cell-Free DNA Levels Are Associated With Reduced Myocardial Blood Flow but Not Angiographic Cardiac Allograft Vasculopathy: The EVIDENT Study.
Cathrine M Moeller, Daniel Oren, Andrea Fernandez Valledor, Gal Rubinstein, Ersilia M DeFilippis
Circulation. Heart Failure. 2024-12-10
Pre-operative pectoralis muscle area index is associated with biomarkers of inflammation and endotoxemia and predicts clinical outcomes after left ventricular assist d...
Matthew R Carey, Annamaria Ladanyi, Mia Nishikawa, Abraham Bordon, Jay S Leb
Artificial Organs. 2024-12-01

Journal Articles

Characteristics and Outcomes of Recipients of Heart Transplant with Coronavirus Disease 2019
Farhana Latif, Maryjane A Farr, Kevin J Clerkin, Koji Takeda, Yoshifumi Naka, Susan Restaino, Gabriel Sayer, Nir Uriel, JAMA Cardiology

Authored Content

Characteristics and Outcomes of Recipients of Heart Transplant with Coronavirus Disease 2019May 2020
Characteristics and Outcomes of Recipients of Heart Transplant with Coronavirus Disease 2019May 2020
Outcomes Associated with Mammalian Target of Rapamycin (mTOR) Inhibitors in Heart Transplant Recipients: A Meta-Analysis☆March 2018
Outcomes Associated with Mammalian Target of Rapamycin (mTOR) Inhibitors in Heart Transplant Recipients: A Meta-Analysis☆March 2018
Join now to see all